Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Xience Registry Study for the Impact of Early Use of Low-Dose Ticagrelor-Based Dual Antiplatelet Therapy to Clinical Outcomes in Patient Undergoing Percutaneous Coronary Interventions for Complex Lesions

NCT05746416 is registered in ClinicalTrials.gov with Hanyang University Seoul Hospital as lead sponsor.

NCT NCT05746416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05746416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Xience Registry Study for the Impact of Early Use of Low-Dose Ticagrelor-Based Dual Antiplatelet Therapy to Clinical Outcomes in Patient Undergoing Percutaneous Coronary Interventions for Complex Lesions
Lead sponsor
Hanyang University Seoul Hospital
Phase
Observational
Overall status
Completed
Start date
January 2, 2019
Completion date
December 31, 2021
Enrollment
977 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, coronary artery disease, percutaneous coronary intervention